Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1982 4
1983 1
1984 4
1985 1
1986 4
1987 6
1988 2
1989 4
1990 5
1991 2
1992 3
1993 5
1994 5
1995 3
1996 1
1997 4
1998 2
1999 4
2000 6
2001 8
2002 9
2003 9
2004 15
2005 14
2006 7
2007 15
2008 15
2009 15
2010 13
2011 6
2012 4
2013 8
2014 11
2015 12
2016 9
2017 16
2018 23
2019 10
2020 8
2021 13
2022 7
2023 11
2024 6
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

319 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
Treatment for cellulite.
Sadick N. Sadick N. Int J Womens Dermatol. 2018 Oct 22;5(1):68-72. doi: 10.1016/j.ijwd.2018.09.002. eCollection 2019 Feb. Int J Womens Dermatol. 2018. PMID: 30809581 Free PMC article. Review.
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere).
Simpson EL, Gooderham M, Wollenberg A, Weidinger S, Armstrong A, Soung J, Ferrucci S, Lima RG, Witte MM, Xu W, ElMaraghy H, Natalie CR, Pierce E, Blauvelt A; ADhere Investigators. Simpson EL, et al. JAMA Dermatol. 2023 Feb 1;159(2):182-191. doi: 10.1001/jamadermatol.2022.5534. JAMA Dermatol. 2023. PMID: 36630140 Free PMC article. Clinical Trial.
Topical Treatments for Photoaged Skin.
Sadick N, Pannu S, Abidi Z, Arruda S. Sadick N, et al. J Drugs Dermatol. 2023 Sep 1;22(9):867-873. doi: 10.36849/JDD.7753. J Drugs Dermatol. 2023. PMID: 37683070 Review.
The Hair Comeback.
Sadick NS. Sadick NS. Dermatol Clin. 2021 Jul;39(3):ix. doi: 10.1016/j.det.2021.04.005. Epub 2021 May 13. Dermatol Clin. 2021. PMID: 34053600 Free PMC article. No abstract available.
Cosmetic dermatology.
Sadick NS, Krueger N. Sadick NS, et al. Dermatol Clin. 2014 Jan;32(1):xi. doi: 10.1016/j.det.2013.10.001. Dermatol Clin. 2014. PMID: 24267427 No abstract available.
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.
Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J; IXORA-R Study Group. Blauvelt A, et al. Br J Dermatol. 2020 Jun;182(6):1348-1358. doi: 10.1111/bjd.18851. Epub 2020 Jan 15. Br J Dermatol. 2020. PMID: 31887225 Free PMC article. Clinical Trial.
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Stein Gold L, Baldwin H, Kircik LH, Weiss JS, Pariser DM, Callender V, Lain E, Gold M, Beer K, Draelos Z, Sadick N, Pillai R, Bhatt V, Tanghetti EA. Stein Gold L, et al. Among authors: sadick n. Am J Clin Dermatol. 2022 Jan;23(1):93-104. doi: 10.1007/s40257-021-00650-3. Epub 2021 Oct 21. Am J Clin Dermatol. 2022. PMID: 34674160 Free PMC article. Clinical Trial.
319 results